Covid-19 Resource Center

Covid-19 Resource Center

During these turbulent times, finding information is hard. The Quadax Resource Center will help keep you up to date on the latest COVID-19 topics, including laboratory testing, supply needs and payor and billing changes affecting reimbursement.

COVID-19 Payer Updates

Quadax is dedicated to keeping our clients up-to-date on the billing, reporting, and procedural information specific to each payer as it pertains to COVID-19.

Recent Blog Posts

The COVID-19 Evolution—Variants and Vaccines

Viruses are constantly changing, and this includes SARS-CoV-2, the virus that causes COVID-19. These genetic variations occur over time and can lead to the emergence of new variants that may have different characteristics. Although none of the experts know exactly how COVID-19 will evolve or how the vaccines will affect the spread, it seems like there is a general consensus among the medical community that COVID-19 will be around for some time.

COVID-19 Articles, Bulletins, Town Halls, Webinars

Date

Article

Source

7/21/2021

Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing

7/20/2021

Lab Advisory: SARS-CoV-2 Variant Classification Updates

7/18/2021

Lab Alert: FDA Revokes EUA for Curative SARS-CoV-2 Assay

7/15/2021

Lab Advisory: CDC Updates Pooling Guidance and Overview of Testing for SARS-CoV-2 Web Pages

7/13/2021

Revised fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination.

7/8/2021

COVID-19 Snapshot: Impact on the Medicare Population

7/8/2021

COVID-19 Accelerated and Advance Payments: Updated FAQs. 

7/6/2021

Lab Advisory: SARS-CoV-2 Variants AY.1 and AY.2 Now Aggregated with Delta Variant B.1.617.2

6/30/2021

CDC Launches New COVID-19 Viral Testing Tool

6/29/2021

Lab Update: SARS-CoV-2 Variant Classification Changes

6/17/2021

CMS Infographic: Medicare Payment for COVID-19 Vaccination Administered in the Home

6/16/2021

CDC Updates Guidance for Reporting SARS-CoV-2 Sequencing Results.

6/15/2021

Coronavirus (COVID-19) Update

6/14/2021

Lab Alert: Sodium Citrate Blood Specimen Collection Tubes in Short Supply

6/14/2021

Lab Advisory: CDC Launches New COVID-19 Viral Testing Tool

6/10/2021

CMS increase provider payment for in-home COVID-19 vaccinations

6/9/2021

Biden Administration Continues Efforts to Increase Vaccinations by Bolstering Payments for At-Home COVID-19 Vaccinations for Medicare Beneficiaries

6/9/2021

HHS Secretary Xavier Becerra to Insurers & Providers: COVID-19 Vaccines and Testing Must be Free for Patients

5/28/2021

Lab Advisory: CDC Updates Testing Strategies for SARS-CoV-2 Web Page

5/25/2021

Coronavirus (COVID-19) Update: May 25, 2021

5/25/2021

HHS to Dedicate $4.8 Billion from American Rescue Plan to COVID-19 Testing for the Uninsured

5/21/2021

Coronavirus (COVID-19) Update: May 21, 2021

5/20/2021

Lab Advisory: CDC Updates NAATs and Self-Testing Web Pages

5/19/2021

Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication

5/18/2021

CDC Updates Interim Guidance for Antigen Testing for SARS-CoV-2

5/5/2021

SARS-CoV-2 Variant Classifications and Definitions

5/3/2021

HHS Launches New Reimbursement Program for COVID-19 Vaccine Administration Fees not Covered by Insurance

4/26/2021

Time to Say Goodbye to Some Insurers’ Waivers for Covid Treatment Fees

4/21/2021

FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines

4/20/2021

The FDA issued a pooling and serial testing amendment for many molecular diagnostic COVID-19 tests that had received an emergency use authorization (EUA) for testing individual samples.

4/16/2021

Medicare FFS Claims:
2% Payment Adjustment (Sequestration) Suspended Through December

4/15/2021

Message from HHS-OIG Leadership on the COVID-19 Vaccination Program and Provider Compliance

4/6/2021

The FDA issued an Emergency Use Authorization (EUA) to Symbiotica, Inc., for the COVID-19 Self-Collected Antibody Test System

4/2/2021

HHS Secretary Xavier Becerra Announces Expansion of COVID-19 Vaccine Program to All Community Health Centers Across the Country

4/2/2021

New web page posted: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular, antigen, and serology tests

4/1/2021

Repayment of COVID-19 Accelerated and Advance Payments Began on March 30, 2021

3/30/2021

Updated Serology EUA COVID-19 Templates Available

3/30/2021

New FDA web page - SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests - for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular tests

3/26/2021

FDA issues emergency use authorization (EUA) to the Twist Bioscience Corporation for their SARS-CoV-2 NGS Assay

3/26/2021

Lab Advisory: CDC Publishes New Web Page on Nucleic Acid Amplification Tests (NAATs)

3/22/2021

Lab Update: CMS Posts FAQ for Reporting Sequencing Results for SARS-CoV-2 Variants

3/15/2021

Medicare Payment Increase for COVID-19 Vaccine

3/13/2021

Lab Alert: FDA Issues Letter about Potential False Results with Roche cobas SARS-CoV-2 & Influenza Test

3/9/2021

Senate Passes $1.9 Trillion COVID-19 Bill; Several CAP-Backed Provisions Move Forward

3/9/2021

FDA issued an Emergency Use Authorization (EUA) to Cue Health Inc. for its over-the-counter at-home diagnostic test for COVID-19.

3/9/2021

Medicare Part B Payment for COVID-19 Vaccines and Certain Monoclonal Antibodies during the Public Health Emergency

3/5/2021

COVID-19 Update: FDA Issues Authorization for First Molecular Non-Prescription, At-Home Test

3/4/2021

COVID-19 Vaccine Administration: Insurance Coverage, MBI, & MSP

3/2/2021

Lab Advisory: FDA Issues New Guidance for Evaluating Impact of Viral Mutations on COVID-19 Tests

3/2/2021

COVID-19 Update: The agency issued an Emergency Use Authorization (EUA) to Quidel for its QuickVue At-Home COVID-19 Test for at-home use with a prescription

2/27/2021

House Approves Large COVID-19 Relief Bill; Includes $7.5 Billion for Vaccine Distribution

2/26/2021

Biden Administration Strengthens Requirements that Plans and Issuers Cover COVID-19 Diagnostic Testing Without Cost Sharing and Ensures Providers are Reimbursed for Administering COVID-19 Vaccines to Uninsured

2/26/2021

ACLA Statement on President Biden’s Actions to Close Coverage Gaps for COVID-19 Testing

2/12/2021

COVID-19 Update:  The FDA revised its guidance, Investigational COVID-19 Convalescent Plasma and associated web page, to reflect the reissued Emergency Use Authorization for COVID-19 convalescent plasma

2/11/2021

COVID-19: Revised Clinician Codes Accepted with CS Modifier

2/3/2021

COVID-19 Claims Reimbursement Program Update for the Uninsured

2/2/2021

Lab Advisory: CDC Publishes New Web Pages on Genomic Surveillance for SARS-CoV-2 Variants

1/29/2021

COVID-19 Update: The FDA has added content to the Q&A appendix in “Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency"

1/28/2021

HHS Announces Marketplace Special Enrollment Period for COVID-19 Public Health Emergency

1/21/2021

ACLA Statement on President Biden's Actions to Combat COVID-19

1/19/2021

Find your COVID-19 Vaccine CPT® Codes

1/8/2021

FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff

1/8/2021

Coronavirus (COVID-19) Update: January 8, 2021

1/4/2021

New ICD-10-CM code for the
2019 Novel Coronavirus (effective 1/1/21)

12/22/2020

Coronavirus (COVID-19) Update: December 22, 2020

12/19/2020

CMS Updates FAQs for CLIA Guidance during the COVID-19 Public Health Emergency

12/15/2020

FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine

12/15/2020

FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19

12/11/2020

COVID-19 and in vitro diagnostics: New market forces at play

12/10/2020

CMS offers guidance in billing Medicare for COVID-19 antibody treatment

12/10/2020

FAQs–Application of OIG's Administrative Enforcement Authorities to Arrangements Directly Connected to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency

12/7/2020

Lab Advisory: CMS Revises Enforcement Discretion for SARS-CoV-2 Point-of-Care Tests

12/5/2020

Lab Update: CDC Updates SARS-CoV-2 Antigen Testing Guidance

12/3/2020

Lab Update: CDC Offers New COVID-19 Specimen Collection Infographics

12/4/2020

13 insurers extending COVID-19 cost-sharing waivers into 2021

12/3/2020

COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) Billing

12/1/2020

Job Aids for Laboratory Professionals

12/1/2020

Clinical Laboratory COVID-19 Response Calls

11/24/2020

Guidance for SARS-CoV-2 Point-of-Care Testing

11/24/2020

Pathologists Advocate for Higher COVID-19 Payments During AMA Meeting

11/24/2020

A Closer Look at COVID-19 Diagnostic Testing

11/23/2020

2020 Clinical Lab & Pathology Resources

11/19/2020

HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19

11/18/2020

Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation

11/18/2020

The FDA issued an EUA for the first COVID-19 diagnostic test for self-testing at home that provides rapid results

11/18/2020

The FDA published a new "FDA Insight" podcast titled: "Personal Protective Equipment and COVID-19"

11/17/2020

CAP Members Call on Congress to Stop Medicare Cuts

11/17/2020

CAP Asks CMS to Reduce COVID-19 Laboratory Reporting Burdens, Increase Testing Resources

11/11/2020

CMS Details Medicare Payment for New COVID-19 Antibody Drug

11/10/2020

AMA Announces Vaccine-Specific CPT Codes for COVID-19 Immunizations

11/9/2020

The FDA issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients

11/2/2020

Clinical Laboratories Need Creative Staffing Strategies to Keep and Attract Hard-to-Find Medical Technologists, as Demand for COVID-19 Testing Increases